Guotai Asset Management says China innovative drug stocks pull back after rally, sees dip-buying windowPUBT·Aug 21 at 04:23 AMBBH-0.28%LABD+0.34%
China's Humanoid Robot Products Exceed 400 Models, Accounting for Over Half of Global TotalAASTOCKS News·Jul 20 at 01:00 AM513060-1.00%159859-2.21%
MoneyMasters Podcast: Where to Invest NOW in AI, Biotech, Small Caps, & Gold!Barchart Option·Jul 16 at 10:58 AMGLL-0.59%159859-2.21%
China's 1H25 Innovative Drug Out-Licensing Deal Value Rises to USD110 Billion, Hitting Fresh Record HighAASTOCKS News·Jul 13 at 04:25 AM159837-1.56%159859-2.21%
China's Outbound Licensing of Innovative Drugs in First Half Nears Last Year's TotalYicai·Jul 13 at 02:28 AM159859-2.21%513700-0.90%
Guotai Asset Management flags China pharma re-rating as 2026 essential drugs list adds 165 medicinesPUBT·Jul 10 at 04:25 AM520690-1.55%520880-1.46%
HSI Company: Hang Seng Biotech Index Rebounds 17%+ from Jun Trough as Constituents Step Up Share BuybacksAASTOCKS News·Jul 9 at 09:35 PM0HSCI159102-1.16%
China’s biotech boom: RAS-targeted drugs challenge US dominanceSCMP·Jul 8 at 03:05 AM01276-1.88%600276-0.61%
SH Comp Gains 3 Pts at Half-Day; HUA HONG GRACE Surges Over 11%, Innovative Drug Concept Stocks RallyAASTOCKS News·Jul 5 at 11:05 PM399001-0.68%06969-1.33%
Biomarkers Market worth $112.10 billion by 2031 | MarketsandMarkets™Unusual Whales·Jul 3 at 09:32 AMARKG+0.85%159102-1.16%
China’s biotech boom: record 5,215 clinical drug trials reported in 2025SCMP·Jun 23 at 07:02 PM159615-1.26%159992-1.49%
China’s Clinical Trial Registrations Surpass 5,000 for First Time in 2025Yicai·Jun 23 at 04:22 AM513060-1.00%159837-1.56%
<![CDATA[New FDA Draft Guidance Targets Gene Therapy Submission Burden by Allowing Use of Existing CMC and Scientific Knowledge]]>Pharmexec·Jun 3 at 11:07 AM159849-1.74%510660-1.07%
BRIEF: WuXi Biologics maintains full-year revenue guidance for up to 17% growthBambooWorks·Jun 1 at 01:05 AM02269+0.99%WXXWY-0.54%
